| 引用本文: |
杨燕,唐密,何江江.医保药品目录调整视角下的卫生技术评估多维度决策框架研究*[J].中国卫生经济,2023,42(11):28-32.[点击复制] |
Yang Yan,Tang Mi,He Jiangjiang.A Study on the Multidimensional Decision Framework for Health Technology Assessment from the Perspective of Ad⁃ justing the Medical Insurance Drug Catalog[J].CHINESE HEALTH ECONOMICS,2023,42(11):28-32.[点击复制] |
|
| 摘要: |
| 目的：基于证据与价值对决策的影响构建医保目录药品遴选的多维度决策框架，解决医保药品目录调整面临多利益相关者、多维度价值的难题。方法：根据多准则决策分析实施步骤，初步构建起医保目录药品调整多维度决策框架；邀请医保、医药、医疗等相关工作领域专家，采用两轮德尔菲法形成指标及其权重。结果：形成疾病、临床、经济、创新、公平及证据6个维度，疾病严重程度、疾病影响人群范围、有效性及安全性等14项准则的指标框架。结论：利用证据与价值对策的影响建立的多维度决策指标框架具有较强实用价值，可以为医保目录药品调整决策提供技术支持。 |
| 关键词: 医保药品 多维度 卫生技术评估 |
| DOI： |
| 投稿时间：2023-08-19 |
| 基金项目:首都医科大学国家医疗保障研究院开放性课题面上项目( YB2020B06)；上海市卫健委卫生行业临床研究专项面上项目 （21940319） |
|
| A Study on the Multidimensional Decision Framework for Health Technology Assessment from the Perspective of Ad⁃ justing the Medical Insurance Drug Catalog |
| Yang Yan,Tang Mi,He Jiangjiang |
| (Shanghai Health Development Research Center, Shanghai, 200040 , China) |
| Abstract: |
| Objective: To construct a multi-dimensional decision-making framework for the selection of drugs in the medical insurance catalogue based on the Evidence and Value: Impact on Decision Making (EVIDEM), so as to solve the problem of multi-stakeholder and multi-dimensional value in the adjustment of the medical insurance drug catalog. Methods: According to the steps of Multi-criteria decision analysis (MCDA), a multi-dimensional decision-making framework for drug adjustment in the medical insurance catalogue was preliminarily constructed. Experts in medical insurance, medicine, medical treatment and other related work fields are invited to form indicators and their weights by two rounds of Delphi method. Results: An index structure of 14 criteria was formed, including disease, clinical, economic, innovation, fairness and evidence, and 14 criteria, including disease severity, disease affected population, efficacy and safety. Conclusion: The multi-dimensional decision-making index framework established by EVIDEM has strong practical value and can provide technical support for the adjustment decision of medical insurance catalogue drugs. |
| Key words: medical insurance drugs multidimensional health technology assessment |
